Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

780.50INR
28 Aug 2015
Change (% chg)

Rs1.45 (+0.19%)
Prev Close
Rs779.05
Open
Rs784.00
Day's High
Rs799.90
Day's Low
Rs777.95
Volume
36,471
Avg. Vol
41,830
52-wk High
Rs888.00
52-wk Low
Rs591.25

Search Stocks
Ipca Laboratories Ltd. is an India-based pharmaceutical company. The Company's formulations business in India consists of 13 marketing divisions focusing on therapeutic segments, including non-steroidal anti-inflammatory drugs (NSAID), cardiovascular and anti-diabetics, anti-malarial, anti-bacterial, gastro intestinal (GI) products, cough preparations, dermatology, neuro psychiatry, urology, neutraceutical and others. The Company manufactures over 350 formulations and 80 active pharmaceutical ingredients (API). The Company also offers Disease Modifying Anti-Rheumatic Drugs treatment for rheumatoid arthritis. The Company exports its APIs to the United States, Canada, Brazil, Mexico and generic formulations to the United States, Canada and branded formulations to Panama, West Indies, Venezuela, Peru and Colombia in this sub-continent.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks